CALLAN JMB INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| CALLAN JMB INC. | |
| By: | /s/ Wayne Williams |
| Wayne Williams | |
| Chief Executive Officer, President, and Chairman of the Board |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ Wayne Williams | Chief Executive Officer, President (Principal Executive Officer) and Chairman of the Board | March 31, 2026 |
| Wayne Williams | ||
| /s/ Christopher Shields | Interim Chief Financial Officer (Principal Financial and Accounting Officer) | March 31, 2026 |
| Christopher Shields | ||
| /s/ David J. Croyle, M.D. | Chief Medical Officer | March 31, 2026 |
| David J. Croyle, M.D. | ||
| /s/ Eric L. Kash | Executive Vice President, and Director | March 31, 2026 |
| Eric L. Kash | ||
| /s/ Mark Meller | Director (Independent) | March 31, 2026 |
| Mark Meller | ||
| /s/ Liberty Duke | Director (Independent) | March 31, 2026 |
| Liberty Duke | ||
| /s/ Gerald Dial | Director (Independent) | March 31, 2026 |
| Gerald Dial | ||
FINANCIAL STATEMENTS AS OF AND FOR
THE YEARS ENDED
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID #089 ) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | F-3 |
| Consolidated Statements of Operations for the Years Ended December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Stockholders’ / Members Equity for the Years Ended December 31, 2025 and 2024 | F-5 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025 and 2024 | F-6 |
| Notes to the Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.